Investor Alert

Deciphera Pharmaceuticals Inc.



After Hours

 --Quotes are delayed by 20 min

Jan 27, 2023, 4:23 p.m.





+0.25 +1.44%


Volume 8,535

Quotes are delayed by 20 min


Previous close

$ 17.98

$ 17.31


-0.67 -3.73%

Day low

Day high




52 week low

52 week high




Daniel C. Martin

Daniel C. Martin is Chief Commercial Officer of Deciphera Pharmaceuticals, Inc.

In the past Mr. Martin occupied the position of Vice President-Marketing & Market Access at Heron Therapeutics, Inc.

Mr. Martin received an undergraduate degree from the University of Virginia and an MBA from The Wharton School of the University of Pennsylvania.


Date Shares Transaction Value
06/16/2022 1,311   Disposition at $10.75 per share. 14,094
02/16/2022 1,146   Disposition at $9.05 per share. 10,372
01/18/2022 13,667   Award at $0 per share. 0
12/15/2021 8,300   Award at $0 per share. 0
01/22/2020 26,999   Disposition at $67.18 per share. 1,813,793
01/22/2020 26,999   Derivative/Non-derivative trans. at $36.1 per share. 974,663
09/19/2019 3,000   Disposition at $35.56 per share. 106,680
09/18/2018 20,000   Award at $0 per share. 0

Officers and Executives

Mr. Steven L. Hoerter
President & Chief Executive Officer
Mr. Thomas P. Kelly
Chief Financial Officer, Treasurer & Executive VP
Dr. Matthew L. Sherman
Chief Medical Officer & Executive Vice President
Dr. Rodrigo Ruiz Soto
Senior Vice President-Clinical Development
Dr. Daniel L. Flynn
Chief Scientific Officer & Executive VP
Dr. Stephen B. Ruddy
Chief Technical Officer & SVP
Ms. Kelley Dealhoy
Chief Business Officer & Senior Vice President
Mr. Daniel C. Martin
Chief Commercial Officer & SVP
Ms. Lisa Amaya Price
Chief Human Resources Officer & Senior VP
Mr. Jeffrey M. Held
General Counsel & Senior Vice President
Mr. Jama Pitman
Vice President-Regulatory & Quality Assurance
Dr. James A. Bristol
Dr. Susan L. Kelley
Independent Director
Mr. Ron Squarer
Independent Director
Mr. Franklin S. Friedman
Independent Director
Ms. Patricia L. Allen
Independent Director
Dr. Edward J. Benz
Independent Director
Mr. John R. Martin
Independent Director
Mr. Dennis L. Walsh
Independent Director
Link to MarketWatch's Slice.